Parenteral Drugs (India) Ltd. - Research Center
524689 PARENTLD Group (Z) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | Sep ' 19 | |
|---|---|---|---|---|---|
| Sales | 3.22 | 5.28 | 7.56 | 15.82 | 16.06 |
| Operating profit | -9.11 | -5.90 | -12.29 | -7.05 | -7.63 |
| Interest | 36.68 | 69.56 | 60.89 | 56.80 | 53.15 |
| Gross profit | -45.74 | -75.44 | -73.15 | -63.63 | -60.76 |
| EPS (Rs) | -3.59 | -22.02 | -22.10 | -19.48 | -18.78 |
Half yearly
results in details
| Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | Sep ' 19 | |
|---|---|---|---|---|---|
| Other income | 0.05 | 0.02 | 0.03 | 0.22 | 0.03 |
| Stock adjustment | -0.41 | 0.97 | 0.28 | 0.05 | 1.08 |
| Raw material | 2.76 | 2.15 | 3.73 | 1.96 | 3.23 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 7.42 | 7.37 | 9.28 | 10.13 | 9.07 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 2.55 | 0.70 | 6.57 | 10.72 | 10.31 |
| Provisions made | - | - | - | - | - |
| Depreciation | 31.49 | 8.66 | 8.67 | 8.66 | 8.69 |
| Taxation | -14.31 | -18.46 | -15.93 | -14.22 | -13.44 |
| Net profit / loss | -10.71 | -65.65 | -65.89 | -58.07 | -56.00 |
| Extra ordinary item | 52.21 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 29.82 | 29.82 | 29.82 | 29.82 | 29.82 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -283.32 | -111.79 | -162.60 | -44.58 | -47.53 |
| GPM (%) | -1400.64 | -1422.81 | -964.32 | -396.81 | -377.59 |
| NPM (%) | -327.97 | -1238.09 | -868.62 | -362.13 | -348.04 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis